KRAS and lung cancer: Thus, our clinical data further confirmed that LKB1 loss increased the DNA methylation and expression level of ALKBH5, which resulting in the demethylation of m6A modification on SOX2, SMAD7, and MYC, and maintaining their expression for KRAS mutant lung cancer.